Sfoglia per Autore
Mostrati risultati da 1 a 9 di 9
Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines.
2010-01-01 Fiume L; Manerba M; Vettraino M; Di Stefano G
Human RCAN3 gene expression and cell growth in endothelial cells.
2010-01-01 Canaider S; Vettraino M; Norling LV; Spisni E; Facchin F; Cooper D; Perretti M.
Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells.
2011-01-01 Fiume L.; Manerba M.; Vettraino M.; Di Stefano G.
Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors.
2011-01-01 Fiume L.; Vettraino M.; Manerba M.; Di Stefano G.
Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
2012-01-01 Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G.
Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase.
2012-01-01 Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Roberti M.; Recanatini M.
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1
2013-01-01 Vettraino M; Manerba M; Govoni M; Di Stefano G.
Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells.
2013-01-01 Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M.
NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases
2013-01-01 Di Stefano G; Manerba M; Vettraino M
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. | Fiume L; Manerba M; Vettraino M; Di Stefano G | 2010-01-01 | PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Human RCAN3 gene expression and cell growth in endothelial cells. | Canaider S; Vettraino M; Norling LV; Spisni E; Facchin F; Cooper D; Perretti M. | 2010-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | - | 1.01 Articolo in rivista | - |
| Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. | Fiume L.; Manerba M.; Vettraino M.; Di Stefano G. | 2011-01-01 | EUROPEAN JOURNAL OF PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Inhibition of lactic dehydrogenase as a way to increase the anti-proliferative effect of multi-targeted kinase inhibitors. | Fiume L.; Vettraino M.; Manerba M.; Di Stefano G. | 2011-01-01 | PHARMACOLOGICAL RESEARCH | - | 1.01 Articolo in rivista | - |
| Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. | Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G. | 2012-01-01 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | - | 1.01 Articolo in rivista | - |
| Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. | Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Roberti M.; Recanatini M. | 2012-01-01 | CHEMMEDCHEM | - | 1.01 Articolo in rivista | - |
| Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulationin Burkitt lymphoma cells via NAD/NADH-dependent inhibition of sirtuin-1 | Vettraino M; Manerba M; Govoni M; Di Stefano G. | 2013-01-01 | ANTI-CANCER DRUGS | - | 1.01 Articolo in rivista | - |
| Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. | Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M. | 2013-01-01 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases | Di Stefano G; Manerba M; Vettraino M | 2013-01-01 | CURRENT TOPICS IN MEDICINAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Mostrati risultati da 1 a 9 di 9
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile